Andrew Dudum - Jun 4, 2024 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Soleil Boughton, Attorney-in-Fact
Stock symbol
HIMS
Transactions as of
Jun 4, 2024
Transactions value $
-$6,167,200
Form type
4
Date filed
6/5/2024, 06:47 PM
Previous filing
May 3, 2024
Next filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise $459K +189K $2.43 189K Jun 4, 2024 Direct F1
transaction HIMS Class A Common Stock Sale -$2.35M -119K -63.03% $19.73 69.8K Jun 4, 2024 Direct F1, F2
transaction HIMS Class A Common Stock Sale -$1.41M -69.8K -100% $20.13 0 Jun 4, 2024 Direct F1, F3
transaction HIMS Class A Common Stock Sale -$1.8M -91K -6.94% $19.73 1.22M Jun 4, 2024 Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 F1, F2
transaction HIMS Class A Common Stock Sale -$1.08M -53.5K -4.38% $20.13 1.17M Jun 4, 2024 Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 F1, F3
holding HIMS Class A Common Stock 1.68M Jun 4, 2024 Held by Trustee of AD 2021 GRAT dated 11-1-2021
holding HIMS Class A Common Stock 419K Jun 4, 2024 Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
holding HIMS Class A Common Stock 597K Jun 4, 2024 Held by Trustee of AD 2022 GRAT
holding HIMS Class A Common Stock 892K Jun 4, 2024 Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
holding HIMS Class A Common Stock 1.32M Jun 4, 2024 Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
holding HIMS Class A Common Stock 1.58M Jun 4, 2024 Held by Trustee of AD 2023 GRAT dated 9-5-2023
holding HIMS Class A Common Stock 570K Jun 4, 2024 Held by Trustee of Dudum Family Community Property Trust
holding HIMS Class A Common Stock 1.5K Jun 4, 2024 Held by Trustees of Richard M. Dudum Irrevocable 1 U/A dtd 10/15/1997
holding HIMS Class A Common Stock 2.87M Jun 4, 2024 Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -189K -14.12% $0.00 1.15M Jun 4, 2024 Class A Common Stock 189K $2.43 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 29, 2023 by the Reporting Person.
F2 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.41- $19.995. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00- $20.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4 Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.